6NOVEMBER 2024TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comPharmaceutical companies are increasingly collaborating with contract research organizations and contract manufacturing organizations to tap into their specialized knowledge, advanced technologies and robust infrastructure. This trend is especially prevalent among small and medium-sized enterprises, which often lack the resources to build comprehensive in-house capabilities. Leveraging outsourcing, they can streamline processes, reduce costs and focus more on core activities like innovation and market expansion.According to recent reports, the pharma outsourcing market is estimated to reach $91.4 billion by 2028 at a CAGR of 5.2 percent.Rise in innovative cloud-based platforms, robust cybersecurity measures and blockchain are reshaping the industry. Novel cloud-based platforms enable seamless data sharing, boosting collaboration and scalability while ensuring compliance with regulations. Strong cybersecurity strategies safeguard sensitive information, protecting intellectual property and patient data from potential threats. Meanwhile, blockchain is being adopted to ensure data integrity, enhance transparency, and improve traceability throughout the pharmaceutical supply chain.This edition of Pharma Tech Outlook Europe delves into the recent developments in pharma outsourcing industry and how companies leverage the services to enhance their offerings.It features insights from Luis Berrade, Senior Director, Global Biologics Testing Sales and Ian Wyllie, Director, RightSource Solutions, of Charles River Laboratories who discuss the evolution of biopharmaceutical outsourcing and the limitations of traditional models. It also highlights insights from Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker at Zai Lab who talks about the evolution and benefits of histology-agnostic clinical trials in the development of targeted cancer therapies.The edition also features leading companies such as Hänseler which excels in transforming galenic formulations into market-ready products through its comprehensive and flexible contract design and manufacturing services. Hänseler offers a full range of solutions, from product development to regulatory documentation, ensuring high-quality, customisable solutions for clients entering the Swiss and international markets.In this edition highlighting Top Pharma Outsourcing Companies in Europe 2024, we hope you find the best partner to address your pharma outsourcing needs to drive your projects to success.Let us know your thoughts!Catalysts for Operational Efficiency and Focused GrowthCopyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 15 - 2024, Vol 10 - Issue 15 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizers Ronald DonovanEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul Barbersales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Edwin PaulTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >